Last reviewed · How we verify
Vistide
At a glance
| Generic name | Vistide |
|---|---|
| Sponsor | Gustave Roussy, Cancer Campus, Grand Paris |
| Target | DNA polymerase catalytic subunit |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- Acyclovir-Resistant Mucocutaneous HSV in Immunocompromised Patients
- CMV Retinitis in AIDS Patients
Common side effects
- Nausea
- Fever
- Chills
- Abdominal pain
- Diarrhea
- Vomiting
- Headache
- Anemia
- Neutropenia
- Asthenia
- Infection
- Rash
Serious adverse events
- Nephrotoxicity
- Neutropenia
- Thrombocytopenia
- Hepatotoxicity
- Sepsis
- Cardiomyopathy
- Congestive heart failure
- Pancreatitis
- Encephalopathy
- Death
Key clinical trials
- A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT (PHASE3)
- Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis (PHASE2)
- A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections (PHASE3)
- Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects (PHASE3)
- A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea
- Clinical Trial for Evaluating the Efficacy and Safety of Electrocoagulation vs Topic Sinecatechins vs Topic Cidofovir Within the Treatment to High-grade Anal Intraepithelial Neoplasia in HIV Homosexual Males (PHASE3)
- A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection (PHASE2)
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |